Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Ingle

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancerJ N Ingle, S J Green, D L Ahmann, et al.
Breast Cancer Research and Treatment|July 1, 1997
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancerM Crump, C A Sawka, G DeBoer, et al.
Breast Cancer Research and Treatment|March 1, 1989
Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancerJ C Buckner, J N Ingle, L K Everson, et al.
Cancer|August 15, 1996
Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trialsS R Alberts, J N Ingle, P R Roche, et al.
Cancer|September 15, 1994
Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapyJ N Ingle, S A Kuross, J A Mailliard, et al.
Cancer|August 15, 1993
Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factorsT M Pisansky, J N Ingle, D J Schaid, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 21, 1997
Breast cancer survival and the timing of tumor removal during the menstrual cycleS Chang, B S Hulka, D D Baird, et al.
Cancer Clinical Trials|January 1, 1981
An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Cancer|September 15, 1994
DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancerT E Witzig, J N Ingle, S S Cha, et al.
Cancer Clinical Trials|January 1, 1978
Evaluation of a fixed alternating treatment in patients with advanced breast cancerD L Ahmann, J O'Fallon, M J O'Connell, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancerJ N Ingle, S J Green, D L Ahmann, et al.
Breast Cancer Research and Treatment|July 1, 1997
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancerM Crump, C A Sawka, G DeBoer, et al.
Breast Cancer Research and Treatment|March 1, 1989
Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancerJ C Buckner, J N Ingle, L K Everson, et al.
Cancer|August 15, 1996
Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trialsS R Alberts, J N Ingle, P R Roche, et al.
Cancer|September 15, 1994
Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapyJ N Ingle, S A Kuross, J A Mailliard, et al.
Cancer|August 15, 1993
Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factorsT M Pisansky, J N Ingle, D J Schaid, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 21, 1997
Breast cancer survival and the timing of tumor removal during the menstrual cycleS Chang, B S Hulka, D D Baird, et al.
Cancer Clinical Trials|January 1, 1981
An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Cancer|September 15, 1994
DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancerT E Witzig, J N Ingle, S S Cha, et al.
Cancer Clinical Trials|January 1, 1978
Evaluation of a fixed alternating treatment in patients with advanced breast cancerD L Ahmann, J O'Fallon, M J O'Connell, et al.
Pageof 17